SALIXIN A/S: Financial statements 2014
CVR: 33776748
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
SALIXIN A/S (CVR 33776748) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 196,515 and a net result of DKK -270,244 compared with DKK -487,490 the year before. Equity in the 2014 report amounted to DKK -363,041.
- Gross Profit
- DKK 196,515
- Profit/Loss
- DKK -270,244
- Equity
- DKK -363,041
- Total Assets
- DKK 1,056,074
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 197 t. | -270 t. | -363 t. | - |
| 2013 | - | -26 t. | -487 t. | -93 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
SALIXIN A/S has published its annual report for 2013. Gross profit came to DKK -25,807, and the net result was DKK -487,490.
About SALIXIN A/S
SALIXIN A/S is a Danish company of the type Aktieselskab based in Tylstrup, founded in 2011. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Allan Juul Bech. The board consists of Michael Bundgaard (chair), Allan Juul Bech and Louise Bech. The company is owned by Ny Vraa A/S. The company has 1 employee (2022). In 2025, the company reported a gross profit of DKK 169,447 and a net result of DKK 106,174 compared with DKK 1,051,659 the year before. Equity in the 2025 report amounted to DKK 124,343.